Indiva Q&A
Yes absolutely we intend to have derivative product available once permitted. Our goal was always to focus on quality, and in that mission extends beyond indoor-grown, medical-grade flower, to edibles and other derivative products such as Bhang Chocolate and Ruby Cannabis Sugar.
Thank you. We have suggested to our readers since day 1 that an international presence may also be a key to success. Can you advise us on how INDIVA is doing on that front … Germany …?
We have met with many different distributors as well as government representatives from many other EU countries, including Germany. We recognize the tremendous opportunity in these growing and liberalizing markets, and we continue to pursue partnerships in order to participate and create shareholder value. We also recently received approval from Health Canada to bring in unique cuttings and tissue cultures for CBD strains from our Swiss partner Medropharm.
And … what is meant by “Agreements with US cannabis products companies to use Canada to produce and export internationally”? How will this be effected?
Canada is in a unique position to export product globally given the federal licensing system Health Canada has put in place. Conversely, product cannot travel between US states (let alone be exported out of country). So we are in a unique situation where products made in Canada can find an international market given our ability to export from this “global platform”. Our goal will be to export product from Canada to global markets, where imports are permitted.
65